considerations [fndg]
choice [inbe]
Oral [spco]
Transdermal [ftcn]
Hormone Therapy [topp]
benefit risk [qlco]
Profile [lbpr]
postmenopausal [tmco]
Hormone Therapy [topp]
Initiative [menp]
Study [mnob]
Published [ocac]
study drug [resa]
Combination [qlco]
mg% [qnco]
Conjugated Equine Estrogens [horm, phsu, strd]
2 5 [qnco]
mg% [qnco]
medroxyprogesterone acetate [horm, phsu, strd]
Decreased [qnco]
Risks [qlco]
Colorectal Cancer [neop]
Osteoporotic Fractures [dsyn]
Hip [bpoc]
Increased [qnco]
coronary heart disease [dsyn]
Stroke [dsyn]
Venous [bpoc]
Thromboembolic events [patf]
Same [qlco]
Profile [lbpr]
Seen [qlco]
Estrogen [horm, phsu, strd]
Arm [blor]
Study [mnob]
Trial [resa]
Investigators [prog]
Observed [ftcn]
Conjugated Equine Estrogens [horm, phsu, strd]
mg% [qnco]
medroxyprogesterone acetate [horm, phsu, strd]
Apply [hlca]
Dosages [qnco]
Combined therapy [topp]
Hormone [horm]
Types [qlco]
Estrogens [horm, phsu, strd]
Progestins [horm, phsu, strd]
routes [spco]
Administration [ocac]
Cast [medd]
Long [qlco]
Shadow [ftcn]
doubt [menp]
Safety [hcpp]
Hormone Therapy [topp]
Make [ftcn]
Difficult [qlco]
Reproductive [orgf]
health care professionals [prog]
Counsel [prog]
Women [popg]
Appropriate Treatment [clna]
vasomotor symptom [sosy]
Literature [inpr]
Suggest [idcn]
Estrogens [horm, phsu, strd]
Progestins [horm, phsu, strd]
Alternative [cnce]
Drugs [phsu]
Doses [qnco]
delivery systems [ftcn]
Exhibit [inpr]
Safety [hcpp]
Profile [lbpr]
Conjugated Equine Estrogens [horm, phsu, strd]
mg% [qnco]
medroxyprogesterone acetate [horm, phsu, strd]
Loss [qnco]
Efficacy [qlco]
therapy [ftcn]
Individualized [qlco]
Based [ftcn]
Patient needs [ftcn]
Specific [qlco]
Global Health [grpa]
Risks [qlco]
Need [qlco]
Relief [fndg]
Climacteric [orgf]
symptoms [ftcn]
Low dose [qnco]
effective [qlco]
therapy, hormonal [topp]
Recommendation [idcn]
